Business Description
Prestige Biologics Co Ltd
ISIN : KR7334970001
Compare
Compare
Traded in other countries / regions
334970.Korea IPO Date
2021-03-11Description
Prestige Biologics Co Ltd is a CDMO-dedicated company that provides solutions of development and manufacturing tasks throughout the stages from the research/development, engineering, clinical production, commercial production, clinical support, and IND & BLA filing of biopharmaceutical products. Its product candidate includes HD201 (Herceptin Biosimilar).
Financial Strength
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.35 | |||||
| Equity-to-Asset | 0.46 | |||||
| Debt-to-Equity | 0.68 | |||||
| Debt-to-EBITDA | -64.84 | |||||
| Piotroski F-Score | 4/9 | |||||
| Altman Z-Score | 0.15 | |||||
| Beneish M-Score | -1.49 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | -21.3 | |||||
| 3-Year EBITDA Growth Rate | 48.9 | |||||
| 3-Year EPS without NRI Growth Rate | -7.8 | |||||
| 3-Year FCF Growth Rate | 53.6 | |||||
| 3-Year Book Growth Rate | -19.8 |
Momentum Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 38.93 | |||||
| 9-Day RSI | 36.69 | |||||
| 14-Day RSI | 37.68 | |||||
| 6-1 Month Momentum % | 51.19 | |||||
| 12-1 Month Momentum % | 46.12 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 0.7 | |||||
| Quick Ratio | 0.56 | |||||
| Cash Ratio | 0.29 | |||||
| Days Inventory | 280.85 | |||||
| Days Sales Outstanding | 72.44 | |||||
| Days Payable | 47.03 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -9.2 | |||||
| Shareholder Yield % | -24.2 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | -897.41 | |||||
| Operating Margin % | -2181.4 | |||||
| Net Margin % | -1593.6 | |||||
| FCF Margin % | -1501.51 | |||||
| ROE % | -26.27 | |||||
| ROA % | -8.28 | |||||
| ROIC % | -10.64 | |||||
| ROC (Joel Greenblatt) % | -5.9 | |||||
| ROCE % | -6.71 |
GF Value Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 197.65 | |||||
| PB Ratio | 2.57 | |||||
| Price-to-Tangible-Book | 2.68 | |||||
| EV-to-EBIT | -34.41 | |||||
| EV-to-EBITDA | -296.67 | |||||
| EV-to-Revenue | 301.4 | |||||
| EV-to-FCF | -19.85 | |||||
| Earnings Yield (Greenblatt) % | -2.91 | |||||
| FCF Yield % | -5.81 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Prestige Biologics Co Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil â‚©) | 1,596.805 | ||
| EPS (TTM) (â‚©) | -413 | ||
| Beta | 0.94 | ||
| Volatility % | 52.29 | ||
| 14-Day RSI | 37.68 | ||
| 14-Day ATR (â‚©) | 345.926416 | ||
| 20-Day SMA (â‚©) | 5799.5 | ||
| 12-1 Month Momentum % | 46.12 | ||
| 52-Week Range (â‚©) | 3850 - 7830 | ||
| Shares Outstanding (Mil) | 77.42 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 4 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Prestige Biologics Co Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Prestige Biologics Co Ltd Stock Events
| Event | Date | Price(â‚©) | ||
|---|---|---|---|---|
| No Event Data | ||||
Prestige Biologics Co Ltd Frequently Asked Questions
What is Prestige Biologics Co Ltd(XKRX:334970)'s stock price today?
The current price of XKRX:334970 is â‚©5330.00. The 52 week high of XKRX:334970 is â‚©7830.00 and 52 week low is â‚©3850.00.
When is next earnings date of Prestige Biologics Co Ltd(XKRX:334970)?
The next earnings date of Prestige Biologics Co Ltd(XKRX:334970) is .
Does Prestige Biologics Co Ltd(XKRX:334970) pay dividends? If so, how much?
Prestige Biologics Co Ltd(XKRX:334970) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers